BLRX · BioLineRx Ltd.
AI read · Good for BLRX
The AI's read
These findings could give GLIX1 a role alongside PARP inhibitors in ovarian cancer. The reported tumor-growth reduction supports that possibility. But the results came from lab and animal models, and further study in people is still needed.